Allergy Therapeutics plc's (AGY) "Buy" Rating Reaffirmed at Panmure Gordon

‘s stock had its “buy” rating reaffirmed by equities researchers at Panmure Gordon in a research report issued on Monday, Market Beat Ratings reports. They currently have a GBX 51 price objective on the stock.